Today: 20 May 2026
Ambev Stock Draws Attention Ahead of World Cup
20 May 2026
2 mins read

Ambev Stock Draws Attention Ahead of World Cup

São Paulo, May 20, 2026, 15:03 BRT

  • Ambev shares in São Paulo hovered near R$16.27. The ADR in New York traded at $3.225.
  • Fernando Maffessoni will take over as logistics vice-president on Aug. 1, according to the latest company filing.
  • Investors are digesting the May 5 earnings beat and Brazil beer strength as they look to the World Cup demand setup.

Ambev shares gained in Wednesday afternoon trading, following momentum from a strong first-quarter result. Investors seemed to shrug off a minor management filing and stayed focused on beer volumes, event demand and margins. The stock traded at R$16.27 on the São Paulo exchange, up from R$15.81 at yesterday’s close. Its ADR was at $3.225 in New York, while the Bovespa index was last at 177,968.

Ambev shares are getting attention again after the brewer’s sharp move earlier this month. The stock climbed 14% and was the top gainer on Brazil’s benchmark after first-quarter profit increased. The company cited Carnival and the World Cup as demand drivers.

Ambev’s latest news isn’t about sales. In a May 19 SEC filing, the brewer said its board picked Fernando Maffessoni, now VP of logistics for Middle Americas Zone at Anheuser-Busch InBev, to become Ambev’s vice-president of logistics starting Aug. 1. He will serve through Dec. 31, 2027. He takes over for Paulo André Zagman.

Ambev shares are still reacting to earnings. The company posted first-quarter profit of R$3.89 billion, up 2.1% year on year, with net revenue at R$22.46 billion. Organic net revenue, which adjusts for currency and some structure changes, was up 8.1%. Overall volume barely moved, but Brazil Beer saw volumes edge up 1.2%.

Ambev CEO Carlos Lisboa said it was “a solid start to 2026,” citing better beer volumes, double-digit normalized EBITDA growth and larger margins. EBITDA stands for earnings before interest, taxes, depreciation and amortization, a standard metric for operating performance.

Brazil beer carried most of the load. Ambev said volumes for premium and super-premium labels like Stella Artois, Corona and Original climbed by low-twenties percentages. No-alcohol beer volumes gained in the low-teens, led by Corona Cero and Skol Zero Zero. BEES Marketplace gross merchandise value also doubled in Brazil Beer, the company said.

Cash was a positive factor. Operating cash flow came in around R$3.16 billion. The board cleared a fresh R$700 million interest-on-capital payout, which is the local shareholder payment. The board also kept July 6 as the payment date for a R$1.2 billion tranche from an earlier approval.

Bernstein SocGen bumped its Ambev price target to $3.73 from $3.42 but kept the Market Perform. The note pointed to Heineken’s first-quarter beer volumes in Brazil dropping low single digits, while Ambev turned in better volume growth. The competitive read is mixed, not dull.

Ambev says it is the biggest brewer by volume in Latin America. The company sells beer and soft drinks in 18 countries in the Americas and says Anheuser-Busch InBev holds about 62% of its stock and controls the company.

But the rally isn’t on solid ground yet. Ambev’s Brazil Beer cash cost per hectoliter jumped 14.6% in the quarter, mainly because of commodity and FX pressures. The company kept its outlook for Brazil Beer cash costs to climb 4.5% to 7.5% this year. Rising costs risk hitting margins if price hikes or a better product mix don’t keep up.

Macro risk remains. Brazil’s central bank activity index grew 1.3% in the first quarter, then dropped 0.7% in March. Services slid 0.8%. April inflation was 4.39%, with the benchmark rate still at 14.50%. Suno Research economist Rafael Perez said the economy “remained resilient,” but noted restrictive monetary policy held things back. Reuters

Ambev is getting lumped in with other consumer names right now, with investors looking at the stock as a short-term trade ahead of an event, not as a logistics play. The focus moves to how real World Cup demand is, and if premium beer and digital channels can deliver on actual volumes instead of just tidier earnings stories.

Stock Market Today

  • Nvidia Q1 Earnings Beat Expectations, Shares Dip
    May 20, 2026, 4:32 PM EDT. Nvidia reported Q1 earnings, posting revenue of $81.62 billion, surpassing the $79.19 billion forecast. Adjusted EPS reached $1.87, beating estimates around $1.77-$1.78. Data Center revenue hit $75.2 billion, exceeding predictions. The company provided strong Q2 guidance with revenue expected at $91 billion ±2%, above $87.36 billion estimates, signaling robust AI infrastructure demand despite market concerns. Nvidia's networking segment, critical for AI cluster interconnects, is rapidly expanding, driven by products like NVLink and InfiniBand. This marks a strategic expansion beyond GPUs, including partnerships with Amazon Web Services. However, rising political resistance to data center growth due to environmental and local impact remains a risk. Nvidia shares initially fell 3% post-report.

Latest articles

Reddit Pushes Past $150 but Ad Campaign Still Lags

Reddit Pushes Past $150 but Ad Campaign Still Lags

20 May 2026
Reddit shares fell 5.2% to $146.84 late Wednesday, underperforming broader tech indexes despite launching new app-advertising tools. A trust linked to CEO Steve Huffman sold 18,000 shares last week, according to an SEC filing. Reddit reported Q1 revenue of $663 million, up 69% year over year, and set Q2 revenue guidance between $715 million and $725 million.
Nvidia AI Chip Sales Reach $81.6 Billion

Nvidia AI Chip Sales Reach $81.6 Billion

20 May 2026
Nvidia reported record quarterly revenue of $81.6 billion, up 85% from a year earlier, with data-center sales reaching $75.2 billion. The company forecast second-quarter revenue of $91 billion, excluding China data-center compute sales. Nvidia approved an $80 billion share buyback and raised its dividend to 25 cents per share. GAAP earnings per share were $2.39.
HCW Biologics Jumps, Doubles Again as Traders Pile Into Biotech Name

HCW Biologics Jumps, Doubles Again as Traders Pile Into Biotech Name

20 May 2026
HCW Biologics shares surged 122% to $2.35 Wednesday, trading as high as $3.96 on heavy volume after a new securities filing and recent earnings. The company is seeking up to $5.6 million in a stock or warrant offering to fund development of its IL-2 fusion protein, HCW9302. First-quarter revenue rose to $6.54 million, mainly from a licensing deal with Beijing Trimmune Biotech.
Navitas Stock Is Surging Again—The AI Power-Chip Bet Now Has to Prove It Can Sell
Previous Story

Navitas Stock Is Surging Again—The AI Power-Chip Bet Now Has to Prove It Can Sell

Rivian Stock Pops as R2 Ramp Gives Traders a New Reason to Look Again
Next Story

Rivian Stock Pops as R2 Ramp Gives Traders a New Reason to Look Again

Go toTop